Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2025 Earnings Call Transcript November 7, 2025
Operator: Hello, and welcome to Intellia Therapeutics Third Quarter 2025 Financial Results Conference Call. My name is Rocco, and I will be your conference operator today. Please be advised that today’s conference is being recorded. I will now turn the conference over to Jason Fredette, Vice President of Investor Relations and Corporate Communications at Intellia. Please proceed, sir.
Jason Fredette:...
